Population Pharmacokinetics of Galcanezumab, an Anti‐CGRP Antibody, Following Subcutaneous Dosing to Healthy Individuals and Patients With Migraine

A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody

(2019) William Kielbasa et al.   CEPHALALGIA

Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial

(2018) Vladimir Skljarevski et al.   CEPHALALGIA

Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study

(2018) Tina Marie Myers Oakes et al.   CEPHALALGIA

Evaluation of Galcanezumab for the Prevention of Episodic Migraine

(2018) Virginia L. Stauffer et al.   JAMA Neurology

Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention

(2018) Vladimir Skljarevski et al.   JAMA Neurology

Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies

(2018) Virginia Stauffer et al.   Patient Preference and Adherence

Galcanezumab in chronic migraine

(2018) Holland C. Detke et al.   NEUROLOGY

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers

(2017) David Monteith et al.   Frontiers in Pharmacology

Drug Development of Therapeutic Monoclonal Antibodies

(2016) Diane R. Mould et al.   BIODRUGS

Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain

(2014) R.J. Benschop et al.   OSTEOARTHRITIS AND CARTILAGE

Population Pharmacokinetics of Belimumab Following Intravenous Administration in Patients With Systemic Lupus Erythematosus

(2013) Herbert Struemper et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Contribution of Renal and Non-Renal Clearance on Increased Total Clearance of Adalimumab in Glomerular Disease

(2013) Brittney V. Roberts et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Characterizing the Impact of Renal Impairment on the Clinical Pharmacology of Biologics

(2012) Bernd Meibohm et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models

(2011) Martin Bergstrand et al.   AAPS Journal

The immunogenicity of humanized and fully human antibodies

(2010) Fiona A. Harding et al.   mAbs

Monoclonal Antibody Pharmacokinetics and Pharmacodynamics

(2008) W Wang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS